Short latency afferent inhibition in Parkinson's disease patients with dementia

Movement Disorders

Volumn 27, Issue 8, 2012, Pages 1052-1055

  Celebi, Ozlem ^a   Temuçin, Çaǧri Mesut ^a   Elibol, Bulent ^a   Saka, Esen ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Alzheimer's disease; Dementia; Neurophysiology; Parkinson's disease; Parkinson's disease dementia

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; CHOLINERGIC NERVE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DEPTH PERCEPTION; EXECUTIVE FUNCTION; FEMALE; GERIATRIC DEPRESSION SCALE; HUMAN; IN VIVO STUDY; LATENT PERIOD; MALE; MEMORY; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; MOTOR CORTEX; NERVE CONDUCTION; PARKINSON DISEASE; PARKINSON DISEASE DEMENTIA; PRIORITY JOURNAL; SENSORY NERVE; SHORT LATENCY AFFERENT INHIBITION; TRANSCRANIAL MAGNETIC STIMULATION;

AFFERENT PATHWAYS; AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; DEMENTIA; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MALE; MOTOR CORTEX; NEUROPSYCHOLOGICAL TESTS; PARASYMPATHETIC NERVOUS SYSTEM; PARKINSON DISEASE; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84864013420     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25040     Document Type: Article

References (31)

1. Candy JM, Perry RH, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J Neurol Sci 1983; 59: 277-289.
2. Whitehouse PJ, Hedreen JC, White CL, Price DL. Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 1983; 13: 243-248.
3. Di Lazzaro V, Oliviero A, Profice P, et al. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res 2000; 135: 455-461.
4. Tokimura H, Di Lazzaro V, Tokimura Y, et al. Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol (London) 2000; 523: 503-513.
5. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
6. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22: 1689-1707; quiz, 1837.
7. Nielsen JE, Jennum P, Fenger K, Sorensen SA, Fuglsang-Frederiksen A. Increased intracortical facilitation in patients with autosomal dominant pure spastic paraplegia linked to chromosome 2p. Eur J Neurol 2001; 8: 335-339.
8. Saka E, Mihci E, Topcuoglu MA, Balkan S. Enhanced cued recall has a high utility as a screening test in the diagnosis of Alzheimer's disease and mild cognitive impairment in Turkish people. Arch Clin Neuropsychol 2006; 21: 745-751.
9. Ertan T, Eker E. Reliability, validity, and factor structure of the geriatric depression scale in Turkish elderly: are there different factor structures for different cultures? Int Psychogeriatr 2000; 12: 163-172.
10. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State". A practical method for grading cognitive state of patients for clinician. J Psychiatr Res 1975; 12: 189-198.
11. Saka E, Elibol B. Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction. Parkinsonism Relat Disord 2009; 15: 688-691.
12. Cangoz B, Karakoc E, Selekler K. Trail Making Test: normative data for Turkish elderly population by age, sex, and education. J Neurol Sci 2009; 283: 73-78.
13. Grober E, Buschke H, Crystal H, Bang S, Dresner R. Screening for dementia by memory testing. Neurology 1988; 38: 900-903.
14. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983; 17: 37-49.
15. Di Lazzaro V, Oliviero A, Tonali PA, et al. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 2002; 59: 392-397.
16. Nardone R, Bergmann J, Kronbichler M, et al. Abnormal short latency afferent inhibition in early Alzheimer's disease: a transcranial magnetic demonstration. J Neural Transm 2008; 115: 1557-1562.
17. Di Lazzaro V, Pilato F, Dileone M, et al. In vivo functional evaluation of central cholinergic circuits in vascular dementia. Clin Neurophysiol 2008; 119: 2494-2500.
18. Di Lazzaro V, Pilato F, Dileone M, et al. In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology 2006; 66: 1111-1113.
19. Nardone R, Florio I, Lochner P, Tezzon F. Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study. Exp Brain Res 2005; 163: 128-131.
20. Sakuma K, Murakami T, Nakashima K. Short latency afferent inhibition is not impaired in mild cognitive impairment. Clin Neurophysiol 2007; 118: 1460-1463.
21. Arendt T, Bigl V, Arendt A, Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans, and Korsakoff's disease. Acta Neuropathol 1983; 61: 101-108.
22. Sailer A, Molnar GF, Paradiso G, Gunraj CA, Lang AE, Chen R. Short and long latency afferent inhibition in Parkinson's disease. Brain 2003; 126: 1883-1894.
23. Kuhl DE, Minoshima S, Fessler JA, et al. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol 1996; 40: 399-410.
24. Manganelli F, Vitale C, Santangelo G, et al. Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. Brain 2009; 132: 2350-2355.
25. Martorana A, Mori F, Esposito Z, et al. Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients. Neuropsychopharmacology 2009; 34: 2323-2328.
26. Di Lazzaro V, Pilato F, Dileone M, et al. Functional evaluation of cerebral cortex in dementia with Lewy bodies. Neuroimage 2007; 37: 422-429.
27. Rizzo V, Arico I, Liotta G, et al. Impairment of sensory-motor integration in patients affected by RLS. J Neurol 2010; 257: 1979-1985.
28. Berlanga ML, Simpson TK, Alcantara AA. Dopamine D5 receptor localization on cholinergic neurons of the rat forebrain and diencephalon: a potential neuroanatomical substrate involved in mediating dopaminergic influences on acetylcholine release. J Comp Neurol 2005; 492: 34-49.
29. Sarter M, Bruno JP, Turchi J. Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implications for neuropsychiatric disorders. Ann N Y Acad Sci 1999; 877: 368-382.
30. Di Lazzaro V, Oliviero A, Pilato F, et al. Neurophysiological predictors of long term response to AChE inhibitors in AD patients. J Neurol Neurosurg Psychiatry 2005; 76: 1064-1069.
31. Nardone R, Golaszewski S, Ladurner G, Tezzon F, Trinka E. A review of transcranial magnetic stimulation in the in vivo functional evaluation of central cholinergic circuits in dementia. Dement Geriatr Cogn Disord 2011; 32: 18-25.